These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 4327587)

  • 21. Rabbit macrophage interferons. I. Conditions for biosynthesis by virus-infected and uninfected cells.
    Smith TJ; Wagner RR
    J Exp Med; 1967 Apr; 125(4):559-77. PubMed ID: 4163879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stabilization of interferon messenger RNA activity by treatment of cells with metabolic inhibitors and lowering of the incubation temperature.
    Vilcek J; Havell EA
    Proc Natl Acad Sci U S A; 1973 Dec; 70(12):3909-13. PubMed ID: 4544057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical events during interferon synthesis in L cells infected with Newcastle disease virus.
    Lancz GJ; Johnson TC
    Proc Soc Exp Biol Med; 1971 Apr; 136(4):1078-81. PubMed ID: 5554448
    [No Abstract]   [Full Text] [Related]  

  • 24. Interferon production by human-mouse hybrid cells: dominant mouse control of superinduction and priming.
    Graves HE; Meager A
    J Gen Virol; 1980 Apr; 47(2):489-95. PubMed ID: 6154131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of dibutyryl cyclic AMP on interferon production by cells treated with viral or nonviral inducers. 1.
    Dianzani F; Neri P; Zucca M
    Proc Soc Exp Biol Med; 1972 Sep; 140(4):1375-8. PubMed ID: 4341562
    [No Abstract]   [Full Text] [Related]  

  • 26. Factors affecting the production of bovine type I interferon on bovine embryonic lung cells by polyriboinosinic-polyribocytidylic acid.
    Rossi CR; Kiesel GK
    Am J Vet Res; 1980 Apr; 41(4):557-60. PubMed ID: 6157341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased susceptibility of cells treated with interferon to the toxicity of polyriboinosinic-polyribocytidylic acid.
    Stewart WE; De Clercq E; Billiau A; Desmyter J; De Somer P
    Proc Natl Acad Sci U S A; 1972 Jul; 69(7):1851-4. PubMed ID: 4505664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of metabolic inhibitors on viral and polynucleotide induction of chick cell interferon.
    Long WF
    Microbios; 1971 Dec; 4(15):253-9. PubMed ID: 5170748
    [No Abstract]   [Full Text] [Related]  

  • 29. Interferon-inducing characteristics of MM virus.
    Giron DJ; Allen PT; Pindak FF; Schmidt JP
    Appl Microbiol; 1971 Mar; 21(3):387-93. PubMed ID: 4324191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of protein synthesis in Newcastle disease virus infected L cells.
    Lancz GJ; Johnson TC
    Proc Soc Exp Biol Med; 1971 Sep; 137(4):1405-10. PubMed ID: 5138471
    [No Abstract]   [Full Text] [Related]  

  • 31. Study of the priming effect of interferon in L cells. II. Metabolic requirements for the development of primed state.
    Rosztóczy I
    Acta Virol; 1977 Jan; 21(1):1-7. PubMed ID: 15432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on early-appearing interferon in vitro. Production of endotoxin-induced interferon by mouse spleen cells cultured in vitro.
    Kobayashi S; Yasui O; Masuzumi M
    Proc Soc Exp Biol Med; 1969 Jun; 131(2):487-94. PubMed ID: 4891946
    [No Abstract]   [Full Text] [Related]  

  • 33. Early interferon production in human diploid cells induced by Newcastle disease virus in the presence of protein synthesis inhibitors.
    Yoshida I
    Tohoku J Exp Med; 1985 Oct; 147(2):113-24. PubMed ID: 2417384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Control of interferon synthesis: effect of diethylaminoethyl-dextran on induction by polyinosinic-polycytidylic acid.
    Vilcek J; Barmak SL; Havell EA
    J Virol; 1972 Oct; 10(4):614-21. PubMed ID: 4343544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon induction by rice dwarf virus RNA. Antiviral activity in vitro and its stability.
    Takehara M; Suzuki N
    Arch Gesamte Virusforsch; 1973; 40(3):291-9. PubMed ID: 4349395
    [No Abstract]   [Full Text] [Related]  

  • 36. Variable response of normal and transformed mouse cells to interferon inducers.
    Treagan L; Jayne A; Prato C
    Acta Virol; 1976 Feb; 20(1):83-5. PubMed ID: 7948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are cytotoxicity and interferon inducing activity of poly(I).poly(C) invariably linked in interferon-treated L cells.
    De Clercq E; De Somer P
    J Gen Virol; 1975 Apr; 27(1):35-44. PubMed ID: 167107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repeated 'superinduction' of interferon in human diploid fibroblast cultures.
    Wiranowska-Stewart M; Chudzio T; Stewart WE
    J Gen Virol; 1977 Oct; 37(1):221-3. PubMed ID: 915483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EVIDENCE FOR A PERSISTENT VIRAL INFECTION IN A CELL LINE DERIVED FROM BURKITT'S LYMPHOMA.
    HENLEGHENLE W
    J Bacteriol; 1965 Jan; 89(1):252-8. PubMed ID: 14255673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Priming increases the amount of interferon mRNA in poly(rI).poly(rC)-treated L cells.
    Fujita T; Saito S; Kohno S
    J Gen Virol; 1979 Nov; 45(2):301-8. PubMed ID: 94345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.